BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15854638)

  • 1. Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female rats.
    Eleftheriades MI; Lambrinoudaki IV; Christodoulakos GE; Gregoriou OV; Economou EV; Kouskouni EE; Antoniou AG; Perrea DN; Dontas IA; Raptou PD; Lyritis GP; Creatsas GC
    Contraception; 2005 May; 71(5):362-71. PubMed ID: 15854638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study.
    Harel Z; Riggs S; Vaz R; Flanagan P; Harel D; Machan JT
    J Pediatr Adolesc Gynecol; 2010 Feb; 23(1):23-31. PubMed ID: 19647454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
    Nappi C; Di Spiezio Sardo A; Greco E; Tommaselli GA; Giordano E; Guida M
    Obstet Gynecol; 2005 Jan; 105(1):53-60. PubMed ID: 15625142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.
    Castelo-Branco C; Vicente JJ; Pons F; Martínez de Osaba MJ; Casals E; Vanrell JA
    J Reprod Med; 2001 Oct; 46(10):875-9. PubMed ID: 11725730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
    J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model.
    Pennisi P; D'Alcamo MA; Leonetti C; Clementi A; Cutuli VM; Riccobene S; Parisi N; Fiore CE
    J Bone Miner Metab; 2005; 23(2):134-9. PubMed ID: 15750691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats.
    Nzeusseu A; Dienst D; Haufroid V; Depresseux G; Devogelaer JP; Manicourt DH
    Bone; 2006 Mar; 38(3):394-9. PubMed ID: 16249132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
    Vescovi JD; VanHeest JL; De Souza MJ
    Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys.
    Register TC; Jayo MJ; Jerome CP
    Osteoporos Int; 1997; 7(4):348-53. PubMed ID: 9373569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
    Paoletti AM; Orrù M; Lello S; Floris S; Ranuzzi F; Etzi R; Zedda P; Guerriero S; Fratta S; Sorge R; Mallarini G; Melis GB
    Contraception; 2004 Oct; 70(4):293-8. PubMed ID: 15451333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
    Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
    Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
    Massai R; Mäkäräinen L; Kuukankorpi A; Klipping C; Duijkers I; Dieben T
    Hum Reprod; 2005 Oct; 20(10):2764-8. PubMed ID: 15980008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles.
    Hartard M; Kleinmond C; Luppa P; Zelger O; Egger K; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG
    Contraception; 2006 Nov; 74(5):367-75. PubMed ID: 17046377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
    Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
    J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats.
    Haffa A; Krueger D; Bruner J; Engelke J; Gundberg C; Akhter M; Binkley N
    J Bone Miner Res; 2000 May; 15(5):872-8. PubMed ID: 10804016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased urinary calcium loss and lower bone turnover in young oral contraceptive users.
    Zittermann A
    Metabolism; 2000 Aug; 49(8):1078-82. PubMed ID: 10954029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
    Gambacciani M; Spinetti A; Taponeco F; Cappagli B; Piaggesi L; Fioretti P
    Obstet Gynecol; 1994 Mar; 83(3):392-6. PubMed ID: 8127531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats.
    Vanderschueren D; van Herck E; Nijs J; Ederveen AG; De Coster R; Bouillon R
    Endocrinology; 1997 Jun; 138(6):2301-7. PubMed ID: 9165015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children.
    Ward KA; Roberts SA; Adams JE; Mughal MZ
    Bone; 2005 Jun; 36(6):1012-8. PubMed ID: 15876561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.